PRODUCTS / PIPELINE
PIPELINE
The pSivida product portfolio is composed of approved and development stage products and technologies with a primary focus on miniaturized, sustained-release drug delivery systems. Our lead development product, Iluvien, (fluocinolone acetonide for the treatment of diabetic macular edema) is in fully recruited Phase III clinical trials. In addition, we are evaluating multiple therapeutic areas where we believe our technology has potential application. In these areas, we are pursuing partnerships to further the development pipeline.
Click here for more information on partnering with pSivida. »
